Brief: Ambrx Biopharma, Inc Files For Mixed Shelf Of Up To $300 Million – SEC Filing
Oct 17 (Reuters) - Ambrx Biopharma Inc AMAM.O :
* AMBRX BIOPHARMA, INC FILES FOR MIXED SHELF OF UP TO $300
MILLION
– SEC FILING
Source text for Eikon: ID:
Further company coverage: AMAM.O
Recent news on Ambrx Biopharma
See all newsU.S. RESEARCH ROUNDUP-Burlington Stores, Carrols Restaurant Group, Mastec
U.S. STOCKS ON THE MOVE-Core & Main, Commercial Metals, Equifax
U.S. STOCKS ON THE MOVE-Toll Brothers, American Eagle Outfitters, Twilio
Wrapup 1: Drugmakers kick off industry conference with two cancer deals
U.S. STOCKS ON THE MOVE-Moderna, Coinbase, Ambrx Biopharma